Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001000694-25-000021
Filing Date
2025-05-08
Accepted
2025-05-08 07:59:11
Documents
92
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nvax-20250331.htm   iXBRL 10-Q 1083854
2 EX-3.5 nvax-20250331xex35.htm EX-3.5 23965
3 EX-31.1 nvax-20250331xex311.htm EX-31.1 11360
4 EX-31.2 nvax-20250331xex312.htm EX-31.2 11249
5 EX-32.1 nvax-20250331xex321.htm EX-32.1 6293
6 EX-32.2 nvax-20250331xex322.htm EX-32.2 5971
12 nvax-20250331_g1.jpg GRAPHIC 94688
13 nvax-20250331_g2.jpg GRAPHIC 103720
  Complete submission text file 0001000694-25-000021.txt   7565147

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nvax-20250331.xsd EX-101.SCH 53646
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nvax-20250331_cal.xml EX-101.CAL 58350
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nvax-20250331_def.xml EX-101.DEF 259969
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nvax-20250331_lab.xml EX-101.LAB 675965
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nvax-20250331_pre.xml EX-101.PRE 482808
95 EXTRACTED XBRL INSTANCE DOCUMENT nvax-20250331_htm.xml XML 913157
Mailing Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878
Business Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

EIN.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26770 | Film No.: 25923951
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)